On September 18, 2026, Maxim Group initiated coverage of Merlin (NASDAQGM:MRLN) with a “Buy” recommendation. The stock closed at $1.95 on the day of the initiation, down from a pre-action close of $2.06 on September 17, marking a 34.56% decrease from its baseline close of $2.98 on September 11, 2026. Over the past month, the stock has declined by 41.09% from a baseline close of $3.31 on August 18, 2026.
Aggregate consensus data as of September 15, 2026, indicates a mean target price of $9.44, implying a potential increase of 383.85% from the current market price. The latest earnings report, released on August 13, 2026, revealed an EPS of -1.4 against an estimated EPS of -0.2754, with actual revenue of $2,194,000—well below the estimated $3,850,500.
Analyst recommendations remain optimistic, with a total of 10 ratings, including 2 strong buys, 7 buys, and 1 hold, resulting in a positive recommendation percentage of 90.0% as of September 1, 2026. These figures have remained consistent with the prior recommendation period.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
